viewBioLargo, Inc.

BioLargo unveils commercial design for Advanced Oxidation System for treating polluted water

It eliminates bacteria, viruses, and pathogenic organisms, and can reduce pharmaceuticals and antibiotics more effectively than standard systems used to treat wastewater

BioLargo Inc AOS water treatment system
The company’s Advanced Oxidation System is capable of processing 500 gallons of water per minute, a standard flow rate requirement

BioLargo Inc (OTCMKTS:BLGO) is manufacturing a scaled-up commercial prototype of its proprietary water treatment system. 

The company’s Advanced Oxidation System (AOS) is capable of processing 500 gallons of water per minute (GPM), a standard flow rate requirement of commercial applications. 

The design utilizes the Spiral AOS geometry in order to achieve greater flow rate capacity without sacrificing size, the company said, and the commercial model is expected to be the most energy-efficient version to date. The system is modular and scalable by increasing or decreasing the number of AOS spiral reactors.

READ: BioLargo Water launches crowdfunding campaign to get its wastewater treatment technology into poultry processing markets

“Producing a 500 GPM AOS system is the next requisite step in the commercialization of the AOS technology,” BioLargo Engineering President Randall Moore said in a statement. “Moving to this larger scale immediately changes the AOS from a research-focused prototype into a viable, commercial water disinfection option for multiple industries.”

This technology could be scaled to even greater GPM in order to tackle other industrial water treatment applications, the company said.

“As a modular system, much higher flow rates than 500 GPM are possible,” Moore said. “A ten by ten array of 500 GPM AOS units could effectively disinfect 50,000 GPM, needed for large scale applications such as municipal water treatment plants. This important scale-up step brings with it a world of opportunity.”

BioLargo’s technology eliminates bacteria, viruses, and other pathogenic organisms, and can reduce pharmaceuticals and antibiotics more effectively than the standard systems used to treat wastewater.

AOS also requires less power and is more affordable than other processes including chlorination, ozonation and UV radiation.

“This is a momentous day for BioLargo Water and the AOS technology as it puts behind us the question of whether we can scale the AOS technology to meet the high volume needs of the very large water treatment market,” CEO Dennis Calvert said. “It also highlights the collaborative design and manufacturing effort between BioLargo Water and our engineering team at [Biolargo Engineering, Science & Technologies].”

BioLargo has initiated a regulated crowdfunding operation through its subsidiary BioLargo Water Investment Group Inc (BWIG) to secure the necessary funding to launch its patented water treatment technology into the $246 million poultry processing market. 

Contact Andrew Kessel at [email protected] 

Follow him on Twitter @andrew_kessel

Quick facts: BioLargo, Inc.

Price: 0.165 USD

Market: OTCQB
Market Cap: $29.22 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of BioLargo, Inc. named herein, including the promotion by the Company of BioLargo, Inc. in any Content on the Site, the Company receives from...



Full interview: BioLargo announces joint venture with BKT and Tomorrow Water...

BioLargo (OTCQB: BLGO) CEO Dennis Calvert joined Steve Darling from Proactive in Vancouver to discuss the company finalizing their deal with BKT and Tomorrow Water in South Korea.  Calvert discusses what this deal provides Bio Largo and also about the recent announcement about their...

on 18/3/20

2 min read